FDA approves Dr. Reddy's generic Fosamax

MUMBAI, India Dr. Reddy’s Laboratories has received approval from the Food and Drug Administration for a generic form of Merck’s osteoporosis drug Fosamax, according to Reuters.

Fosamax 70 mg had annual sales of approximately $1.7 billion in the U.S., based on IMS sales data for the 12 months that ended November 2007.